> Detailanzeige
Stolbrink, Marie
[VerfasserIn];
Chinouya, Martha J.
[VerfasserIn];
Jayasooria, Shamanthi
[VerfasserIn];
Nightingale, Rebecca
[VerfasserIn];
Evans-Hill, Laura
[VerfasserIn];
Allan, Keith
[VerfasserIn];
Allen, Haddijatou
[VerfasserIn];
Balen, Julie
[VerfasserIn];
Beacon, Tim
[VerfasserIn];
Bissell, Karen
[VerfasserIn];
Chakaya, Jeremiah
[VerfasserIn];
Chiang, Chen-Yuan
[VerfasserIn];
Cohen, Mark
[VerfasserIn];
Devereux, Graham
[VerfasserIn];
ElSony, Asma
[VerfasserIn];
Halpin, David
[VerfasserIn];
Hurst, John R.
[VerfasserIn];
Kiprop, Clement
[VerfasserIn];
Lawson, Anna
[VerfasserIn];
Macé, Cécile
[VerfasserIn];
Makhanu, Agnes
[VerfasserIn];
Makokha, Pancy
[VerfasserIn];
Masekela, Refiloe
[VerfasserIn];
Meme, Hellen
[VerfasserIn];
[...]
Improving Access to Affordable Quality-Assured Inhaled Medicines in Low- and Middle-Income Countries
Teilen
Literatur-
verwaltung
Direktlink
Zur
Merkliste
Lösche von
Merkliste
Per Email teilen
Auf Twitter teilen
Auf Facebook teilen
Per Whatsapp teilen
- Medientyp: E-Book
- Titel: Improving Access to Affordable Quality-Assured Inhaled Medicines in Low- and Middle-Income Countries
- Beteiligte: Stolbrink, Marie [VerfasserIn]; Chinouya, Martha J. [VerfasserIn]; Jayasooria, Shamanthi [VerfasserIn]; Nightingale, Rebecca [VerfasserIn]; Evans-Hill, Laura [VerfasserIn]; Allan, Keith [VerfasserIn]; Allen, Haddijatou [VerfasserIn]; Balen, Julie [VerfasserIn]; Beacon, Tim [VerfasserIn]; Bissell, Karen [VerfasserIn]; Chakaya, Jeremiah [VerfasserIn]; Chiang, Chen-Yuan [VerfasserIn]; Cohen, Mark [VerfasserIn]; Devereux, Graham [VerfasserIn]; ElSony, Asma [VerfasserIn]; Halpin, David [VerfasserIn]; Hurst, John R. [VerfasserIn]; Kiprop, Clement [VerfasserIn]; Lawson, Anna [VerfasserIn]; Macé, Cécile [VerfasserIn]; Makhanu, Agnes [VerfasserIn]; Makokha, Pancy [VerfasserIn]; Masekela, Refiloe [VerfasserIn]; Meme, Hellen [VerfasserIn]; Ming Khoo, Ee [VerfasserIn]; Nantanda, Rebecca [VerfasserIn]; Pasternak, Sarah [VerfasserIn]; Perrin, Christophe [VerfasserIn]; Reddel, Helen [VerfasserIn]; Rylance, Sarah [VerfasserIn]; Schweikert, Peter [VerfasserIn]; Were, Christopher [VerfasserIn]; Williams, Sian [VerfasserIn]; Winders, Tonya [VerfasserIn]; Yorgancioglu, Arzu [VerfasserIn]; Marks, Guy [VerfasserIn]; Mortimer, Kevin [VerfasserIn]
- Erschienen: [S.l.]: SSRN, 2022
- Umfang: 1 Online-Ressource (25 p)
- Sprache: Englisch
- DOI: 10.2139/ssrn.4107776
- Identifikator:
- Entstehung:
-
Anmerkungen:
Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments May 9, 2022 erstellt
- Beschreibung: Background: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low- and middle-income countries (LMICs) causing avoidable morbidity and mortality. The International Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this topic in February 2022.Methods: Focused group discussions were informed by literature and presentations summarising experiences of obtaining inhaled medicines in LMICs. The virtual meeting was moderated using a topic guide around barriers and solutions to improve access. The thematic framework approach was used for analysis. Results: A total of 58 key stakeholders, including patients, healthcare practitioners, members of national and international organisations, industry, and the World Health Organization attended the meeting. 20 submitted pre-meeting materials. The main barriers identified were: (1) low awareness of CRDs; (2) limited data on CRD burden and treatments in LMICs; (3) ineffective procurement and distribution networks; (4) poor communication of the needs of people with CRDs. Solutions discussed were: (1) generation of data to inform policy and practice; (2) capacity building; (3) improved procurement mechanisms; (4) strengthening advocacy; and (5) a World Health Assembly Resolution.Conclusion: There are opportunities to achieve improved access to affordable, quality-assured inhaled medicines in LMICs through coordinated, multi-stakeholder, collaborative efforts
- Zugangsstatus: Freier Zugang